Synthesis and evaluation of pyrimidine-thiadiazole compounds show promise for anticancer development.
is the most promising candidate in this series, with both enhanced cytotoxic activity and favorable docking interactions, suggesting that pyrimidine-thiadiazole hybrids represent a valuable scaffold for further anticancer drug development.
No takes yet. Share an insight, caveat, or question.
Ghoneim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: